Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aroa Biosurgery Ltd (AU:ARX)
ASX:ARX
RESEARCH TOOLSreports
Aroa Biosurgery Ltd (ARX) Share Price & Analysis
24 Followers
ARX Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.48 - AU$1.00
Previous CloseAU$0.61
Volume50.28K
Average Volume (3M)495.53K
Market Cap
AU$209.97M
Enterprise ValueAU$162.07M
Total Cash (Recent Filing)AU$53.35M
Total Debt (Recent Filing)AU$5.46M
Price to Earnings (P/E)―
Beta0.75
Next Earnings
May 20, 2024EPS Estimate
>-AU$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding344,207,834
10 Day Avg. Volume408,356
30 Day Avg. Volume495,529
Standard Deviation0.06
R-Squared0.15
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$1.00Price Target Upside61.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Aroa Biosurgery Ltd News
PremiumCompany Announcements
Aroa Biosurgery Embraces Strong Corporate Governance
PremiumCompany Announcements
Aroa Biosurgery’s Revenue Surge and Clinical Milestone
PremiumCompany Announcements
Aroa Biosurgery Unveils Full-Year Results
PremiumCompany Announcements
Aroa Biosurgery Projects Growth Amidst FY24 Revenue Rise
PremiumCompany Announcements
Acorn Capital Takes Substantial Stake in Aroa BiosurgeryPremiumCompany Announcements
FirstCape Group Acquires Stake in Aroa Biosurgery
PremiumCompany Announcements
Aroa Biosurgery Reports on Regenerative Healing Advances
PremiumCompany Announcements
Aroa Biosurgery Targets Advanced Healing in Q4 ReportOptions Prices
Currently, No data available
---
Ownership Overview
7.60% Insiders
0.07% Mutual Funds
<0.01% Other Institutional Investors
92.34% Public Companies and
Individual Investors
ARX FAQ
What was Aroa Biosurgery Ltd’s price range in the past 12 months?
Aroa Biosurgery Ltd lowest share price was AU$0.47 and its highest was AU$0.99 in the past 12 months.
What is Aroa Biosurgery Ltd’s market cap?
Currently, no data Available
When is Aroa Biosurgery Ltd’s upcoming earnings report date?
Aroa Biosurgery Ltd’s upcoming earnings report date is May 20, 2024 which is 45 days ago.
How were Aroa Biosurgery Ltd’s earnings last quarter?
Aroa Biosurgery Ltd released its earnings results on Nov 27, 2023. The company reported -AU$0.016 earnings per share for the quarter, missing the consensus estimate of -AU$0.014 by -AU$0.003.
Is Aroa Biosurgery Ltd overvalued?
According to Wall Street analysts Aroa Biosurgery Ltd’s price is currently Undervalued.
Does Aroa Biosurgery Ltd pay dividends?
Aroa Biosurgery Ltd does not currently pay dividends.
What is Aroa Biosurgery Ltd’s EPS estimate?
Aroa Biosurgery Ltd’s EPS estimate is >-AU$0.01.
How many shares outstanding does Aroa Biosurgery Ltd have?
Aroa Biosurgery Ltd has 344,207,820 shares outstanding.
What happened to Aroa Biosurgery Ltd’s price movement after its last earnings report?
Aroa Biosurgery Ltd reported an EPS of -AU$0.016 in its last earnings report, missing expectations of -AU$0.014. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Aroa Biosurgery Ltd?
Currently, no hedge funds are holding shares in AU:ARX
---
Aroa Biosurgery Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$1.00 (61.29% Upside)
AU$1.00 (61.29% Upside)
Blogger Sentiment
Bullish
AU:ARX Sentiment 100%
Sector Average 72%
Sector Average 72%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.05%
12-Months-Change
Fundamentals
Return on Equity
-10.81%
Trailing 12-Months
Asset Growth
-6.46%
Trailing 12-Months
Company Description
Aroa Biosurgery Ltd
Aroa Biosurgery Ltd is a soft tissue regeneration company. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The company's principal market is the United States where it has five key products for sale targeting chronicwounds, hernia, plastics, and reconstructive surgery and trauma/limb salvage/tumor surgery.
---
ARX Stock 12 Month Forecast
Average Price Target
AU$1.00
▲(61.29% Upside)
Technical Analysis
Best Analysts Covering ARX
1 Year
1 Year Success Rate
7/15 ratings generated profit
1 Year Average Return
-10.19%
reiterated a buy rating last month
Copying Shane Storey's trades and holding each position for 1 Year would result in 46.67% of your transactions generating a profit, with an average return of -10.19% per trade.
---